Halozyme Therapeutics, Inc.
2019 Q4 - 2025 Q4 (11 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/10/2026 | 7,231 | 0.2% | 107,450 | 12/31/2025 |
| 2025 Q3 | 11/10/2025 | 6,894 | 0.2% | 94,000 | 9/30/2025 |
| 2025 Q2 | 8/12/2025 | 4,911 | 0.2% | 94,400 | 6/30/2025 |
| 2025 Q1 | 5/9/2025 | 6,253 | 0.3% | 98,000 | 3/31/2025 |
| 2024 Q4 | 2/11/2025 | 5,077 | 0.3% | 106,200 | 12/31/2024 |
| 2024 Q3 | 11/12/2024 | 6,073 | 0.5% | 106,100 | 9/30/2024 |
| 2024 Q2 | 8/13/2024 | 5,676 | 0.4% | 108,400 | 6/30/2024 |
| 2024 Q1 | 5/10/2024 | 4,593 | 0.4% | 112,900 | 3/31/2024 |
| 2021 Q1 | 4/22/2021 | 3,243 | 0.3% | 77,800 | 3/31/2021 |
| 2020 Q4 | 2/9/2021 | 3,289 | 0.3% | 77,000 | 12/31/2020 |
| 2019 Q4 | 2/12/2020 | 768 | 0.1% | 43,300 | 12/31/2019 |